Tagrisso Osimertinib 40 mg Tablets

Osimertinib Tablet, a protein kinase inhibitor, is employed in the management of non-small cell lung cancer. Specifically, it is utilized in adult patients exhibiting certain estimated glomerular filtration rate (EGFR) mutations.\n\nWhile Osimertinib Tablet can be ingested with or without food, it is advisable to maintain a consistent daily schedule for maximum benefits. The appropriate dosage and frequency will be determined by the doctor based on the specific condition being treated, and this may be subject to adjustments over time. Strict adherence to the doctor's instructions is crucial, as improper intake or excessive consumption may result in severe side effects. Although the benefits may take weeks or months to become apparent, it is essential not to discontinue the medication unless advised by the doctor.